<figure>
<figcaption>Fig. 5.3 Overall Survival based on 8th edition N category criteria that incorporate ENE as a prognostic factor. Kaplan Meier methods were used to perform cancer-specific analyses predicting overall survival as the endpoint on a population of oral cavity cancer patients from NCDB14</figcaption>
1.0
0.9
0.8
Survival Probability
0.7
0.6
New N-Staging - Lip & Oral Cavity
0.5
NO (n=4,770)
N1 (n=699)
N2A (n=236)
N2B (n=554)
0.4
N2C (n=140)
N3A (n<10)
N3B (n=855)
0.3
0
6
12
18
24
30
36
Months Follow-Up
</figure>

5
Overall Survival - 8th Edition N Category

<figure>
<figcaption>Fig. 5.4 Overall Survival based on 8th edition N category criteria that incorporate ENE as a prognostic factor. Kaplan Meier methods were used to perform cancer-specific analyses predicting overall survival as the endpoint on a population of oral cavity cancer patients from MSKCC and PMH</figcaption>
1.0
0.8
Cum Survival
0.6
0.4
NO
N1
0.2
N2a
N2b
N2c
N3b
0.0
0
12
24
36
48
60
Time (Months)
</figure>

<table>
<caption>Table 5.5 Overall survival based on 8th Edition N category criteria (MSKCC-PMH Data)</caption>
<tr>
<th># of pts at Risk</th>
<th>0 Months</th>
<th>12 Months</th>
<th>24 Months</th>
<th>36 Months</th>
<th>48 Months</th>
<th>60 Months</th>
</tr>
<tr>
<td>NO</td>
<td>1018</td>
<td>870</td>
<td>710</td>
<td>596</td>
<td>513</td>
<td>421</td>
</tr>
<tr>
<td>N1</td>
<td>211</td>
<td>168</td>
<td>119</td>
<td>97</td>
<td>82</td>
<td>70</td>
</tr>
<tr>
<td>N2a</td>
<td>66</td>
<td>50</td>
<td>30</td>
<td>28</td>
<td>21</td>
<td>13</td>
</tr>
<tr>
<td>N2b</td>
<td>148</td>
<td>107</td>
<td>65</td>
<td>49</td>
<td>39</td>
<td>29</td>
</tr>
<tr>
<td>N2c</td>
<td>42</td>
<td>34</td>
<td>22</td>
<td>19</td>
<td>12</td>
<td>8</td>
</tr>
<tr>
<td>N3b</td>
<td>303</td>
<td>146</td>
<td>81</td>
<td>59</td>
<td>43</td>
<td>31</td>
</tr>
</table>

<figure>
<figcaption>Fig. 5.5 Overall Survival based on 7th Edition AJCC/UICC stage groupings using 8th edition T and N criteria. Kaplan Meier methods were used to perform cancer-specific analyses predicting overall survival as the endpoint on a population of oral cavity cancer patients from MSKCC and PMH15</figcaption>
Overall Survival - 7th Edition AJCC/UICC Stage Groupings With 8th Edition T and N Criteria
1.0
0.8
Cum Survival
0.6
0.4
Stage I
0.2
Stage II
-Stage III
Stage IVA
Stage IVB
0.0
0
12
24
36
48
60
Time (Months)
</figure>